22 October 2024
Genus plc
Chief Financial Officer
Retirement
("Genus" or the
"Group")
Genus (LSE: GNS), a leading global animal
genetics company, announces that Alison Henriksen, Chief
Financial Officer, has informed the Board of her intention to
retire after five years with the Group. Alison will remain in her
existing role until 31 July 2025 to assist with the transition and
continue to focus on delivery of the Group's strategic priorities
until her retirement.
The Board has initiated a comprehensive search
for Alison's successor and will provide an update once this process
has concluded.
Jorgen Kokke,
Group Chief Executive Officer, commented:
"On behalf of the Board, I would like to thank
Alison for her support and significant contribution to Genus's
development over the last five years. Alison's financial leadership
has been instrumental in Genus building a strong growth platform
for many years to come. On a personal note, it has been a pleasure
working with Alison, and I'm appreciative of her partnership since
I joined Genus, however I fully understand her desire to create
more time for family, her other interests, and to return to
Australia."
For further
information please contact:
Genus
plc
Tel: +44 125 634 5970
Jorgen Kokke, Chief Executive Officer
Alison Henriksen, Chief Financial
Officer
Anand Date, Investor Relations
Director
Buchanan
Tel: +44 207 466 5000
Charles Ryland; Toto Berger; Sophie Wills;
Verity Parker
About
Genus
Genus is a world-leading animal genetics
company. Genus creates advances to animal breeding and genetic
improvement by applying biotechnology and sells added value
products for livestock farming and food producers. Its technology
is applicable across livestock species and is currently
commercialised by Genus in the dairy, beef and pork food production
sectors.
Genus's worldwide sales are made in over
seventy-five countries under the trademarks 'ABS' (dairy and beef
cattle) and 'PIC' (pigs) and comprise semen, embryos and breeding
animals with superior genetics to those animals currently in farms.
Genus's customers' animals produce offspring with greater
production efficiency, and quality, and use these to supply the
global dairy and meat supply chains.
The Group's competitive edge has been created
from the ownership and control of proprietary lines of breeding
animals, the biotechnology used to improve them and its global
supply chain, technical service and sales and distribution
network.
With headquarters in Basingstoke, United
Kingdom, Genus companies operate in over twenty-five countries on
six continents, with research laboratories located in Madison,
Wisconsin, USA.
Regulatory
notes
Details of Alison's terms of departure will be
consistent with Genus's existing remuneration policy and the terms
will be posted on the Company's website, in accordance with section
430(2B) Companies Act 2006.
